Leptin triggers Ca2+ imbalance in monocytes of overweight subjects

Neuropeptides

Volumn 46, Issue 5, 2012, Pages 203-209

  Padra, János Tamás ^a   Seres, Ildikó ^a   Fóris, Gabriella ^a   Paragh, György ^a,b   Kónya, Gabriella ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b WEISS MEMORIAL HOSPITAL   (United States)

Author keywords

Ca2+ Signal; Calcium; Fluvastatin; Leptin; Monocyte; Obesity

Indexed keywords

CALCIUM ION; FLUINDOSTATIN; LEPTIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LEAN BODY WEIGHT; MALE; MONOCYTE; NORMAL HUMAN; OBESITY; PATHOGENESIS; PLEIOTROPY; PRIORITY JOURNAL;

ADULT; CALCIUM; CALCIUM SIGNALING; HOMEOSTASIS; HUMANS; LEPTIN; MALE; MIDDLE AGED; MONOCYTES; NADPH OXIDASE; OVERWEIGHT;

EID: 84867095904     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2012.07.002     Document Type: Article

References (39)

1. Balla T. Phosphoinositide-derived messengers in endocrine signaling. J. Endocrinol. 2006, 188:135-153.
2. Balogh Z., Fóris G., Kónya G., Paragh G., Köbling T., Padra J.T., Sarang Z., Paragh G. Obesity abrogates the concentration-dependent effect of leptin on endogenous cholesterol synthesis in human monocytes. Immunobiology 2011, 216:431-435.
3. 2+ ATPase 3 gene. J. Biol. Chem. 2004, 279:24297-24306.
4. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., Heath C.W. Body-mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med. 1999, 341:1097-1105.
5. Carnevale R., Pignatelli P., Di Santo S., Bartimoccia S., Sanguigni V., Napoleone L., Tanzilli G., Basili S., Violi F. Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients. Atherosclerosis 2010, 213:225-234.
6. Cartwright E.J., Oceandy D., Neyses L. Physiological implications of the interaction between the plasma membrane calcium pump and nNOS. Pflugers Arch. 2009, 457:665-671.
7. Cohen H.J., Chovaniek M.E. Superoxide generation by digitonin-stimulated guinea pig granulocytes. J. Clin. Invest. 1978, 61:1088-1096.
8. Diebold B.A., Bokoch G.M. Rho GTPases and the control of the oxidative burst in polymorphonuclear leukocytes. Curr. Top. Microbiol. Immunol. 2005, 291:91-111.
9. Fernández-Sánchez A., Madrigal-Santillán E., Bautista M., Esquivel-Soto J., Morales-González A., Esquivel-Chirino C., Durante-Montiel I., Sánchez-Rivera G., Valadez-Vega C., Morales-González J.A. Inflammation, oxidative stress, and obesity. Int. J. Mol. Sci. 2011, 12:3117-3132.
10. Fóris G., Paragh G., Dezso{doubleacute} B., Keresztes T., Balogh Z., Szabó J. Altered postreceptor signal transduction of formyl-Met-Leu-Phe receptors in polymorphonuclear leukocytes of patients with non-insulin-dependent diabetes mellitus. Clin. Immunol. Immunopathol. 1998, 86:95-101.
11. Fortuño A., Bidegain J., Baltanás A., Moreno M.U., Montero L., Landecho M.F., Beloqui O., Díez J., Zalba G. Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications. J. Hypertens. 2010, 28:1944-1950.
12. 2+ mobilization, stimulation of respiratory burst and enzyme secretion. Biochem. Biophys. Res. Commun. 1986, 141:92-98.
13. 2+ efflux from human monocytes with aging. Immunol. Lett. 1987, 14:283-286.
14. Franzoni F., Quinones-Galvan A., Regoli F., Ferrannini E., Galetta F. A comparative study of the in vitro antioxidant activity of statins. Int. J. Cardiol. 2003, 90:317-321.
15. Fritz G. Targeting the mevalonate pathway for improved anticancer therapy. Curr. Cancer Drug Targets 2009, 9:626-638.
16. Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem. J. 2006, 393:7-20.
17. Gerasimenko O., Gerasimenko J. New aspects of nuclear calcium signaling. J. Cell Sci. 2004, 117:3087-3094.
18. Jacob M.P., Fülöp T., Foris G., Robert L. Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts and smooth muscle cells. Proc. Natl. Acad. Sci. 1987, 84:995-999.
19. Koh K.K., Park S.M., Quon M.J. Leptin and cardiovascular disease: Response to therapeutic interventions. Circulation 2008, 117:3238-3249.
20. Kosztáczky B., Fóris G., Seres I., Balogh Z., Fülöp P. Neuropeptides induces a pronounced and statin-sensitive dysregulation of mevalonate cycle in human monocytes of patients with hypercholesterolemia. Neuropeptides 2006, 40:309-316.
21. Kosztáczky B., Fóris G., Paragh G., Seres I., Zsiros E., Koncsos P., Balogh Z., Paragh G. Leptin stimulates endogenous cholesterol synthesis in human monocytes: New role of an old player in atherosclerotic plaque formation. Leptin-induced increase in cholesterol synthesis. Int. J. Biochem. Cell Biol. 2007, 39:1637-1645.
22. Kourie J.L. Interaction of reactive oxygen species with ion transport mechanisms. Am. J. Physiol. 1998, 275:C1-24.
23. Matsuzawa Y. White adipose tissue and cardiovascular disease. Best. Pract. Res. Clin. Endocrinol. Metab. 2005, 19:637-647.
24. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006, 580:2917-2921.
25. Paragh G., Kovacs E., Seres I., Keresztes T., Balogh Z., Szabó J., Teichmann F., Fóris G. Altered signal pathway in granulocytes from patients with hypercholesterolemia. J. Lipid Res. 1999, 40:1728-1733.
26. Paragh G., Szabó J., Kovacs E., Keresztes T., Karpati I., Balogh Z., Páll D., Fóris G. Altered signal pathway in angiotensin II-stimulated neutrophils of patients with hypercholesterolemia. Cell. Signal. 2002, 14:787-792.
27. Patthy M., Balla T., Arányi P. High performance reversed-phase ion pair chromatographic study. J. Chromatography 1990, 523:201-216.
28. Romero-Corral A., Montori V.M., Somers V.K., Korinek J., Thomas R.J., Allison T.G., Mookadam F., Lopez-Jimenez F. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies. Lancet 2006, 368:666-678.
29. Sacksteder C.A., Whittier J.E., Xiong Y., Li J., Galeva N.A., Jacoby M.E., Purvine S.O., Williams T.D., Rechsteiner M.C., Bigelow D.J., Squier T.C. Tertiary structural rearrangements upon oxidation of Methionin 145 in calmodulin promotes targeted proteosomal degradation. Biophys. J. 2006, 91:1480-1493.
30. Schepers E., Glorieux G., Dhondt A., Leybaert L., Vanholder R. Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol. Dial. Transplant. 2009, 24:1429-1435.
31. Seres I., Foris G., Pall D., Kosztaczky B., Paragh G., Varga Z., Paragh G. Angiotensin II-induced oxidative burst is fluvastatin sensitive in neutrophils of patients with hypercholesterolemia. Metabolism 2005, 54:1147-1154.
32. Shi H., Dirienzo D., Zemel M.B. Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J. 2001, 15:291-293.
33. Stark G. Functional consequences of oxidative membrane damage. J. Membr. Biol. 2005, 205:1-6.
34. Visnjic D., Banfic H. Nuclear phospholipid signaling: Phosphatidylinositol-specific phospholipase C and phosphoinositide 3-kinase. Pflugers Arch. 2007, 455:19-30.
35. Wu D., Huang C.K., Jiang H. Roles of phospholipid signaling in chemoattractant-induced responses. J. Cell Sci. 2000, 113:2935-2940.
36. Zemel M.B., Shi H., Greer B., Dirienzo D., Zemel P.C. Regulation of adiposity by dietary calcium. FASEB J. 2000, 9:1132-1138.
37. Zemel M.B. Regulation of adiposity and obesity risk by dietary calcium: Mechanisms and implications. J. Am. Coll. Nutr. 2002, 21:146S-151S.
38. Zemel M.B. The role of dairy foods in weight management. J. Am. Coll. Nutr. 2005, 24:537S-546S.
39. Zhou Q., Liao J.K. Pleiotropic effects of statins - Basic research and clinical perspectives. Circ. J. 2010, 74:818-826.